» Articles » PMID: 32344752

Potential Use of Extracellular Vesicles Generated by Microbubble-Assisted Ultrasound As Drug Nanocarriers for Cancer Treatment

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2020 Apr 30
PMID 32344752
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular vesicles (EVs)-carrying biomolecules derived from parental cells have achieved substantial scientific interest for their potential use as drug nanocarriers. Ultrasound (US) in combination with microbubbles (MB) have been shown to trigger the release of EVs from cancer cells. In the current study, the use of microbubbles-assisted ultrasound (USMB) to generate EVs containing drug cargo was investigated. The model drug, CellTracker™ green fluorescent dye (CTG) or bovine serum albumin conjugated with fluorescein isothiocyanate (BSA FITC) was loaded into primary human endothelial cells in vitro using USMB. We found that USMB loaded CTG and BSA FITC into human endothelial cells (HUVECs) and triggered the release of EVs containing these compounds in the cell supernatant within 2 h after treatment. The amount of EV released seemed to be correlated with the increase of US acoustic pressure. Co-culturing these EVs resulted in uptake by the recipient tumour cells within 4 h. In conclusion, USMB was able to load the model drugs into endothelial cells and simultaneously trigger the release of EVs-carrying model drugs, highlighting the potential of EVs as drug nanocarriers for future drug delivery in cancer.

Citing Articles

Dynamic reorganization of multivesicular bodies and exosome production impacted by sonoporation.

Li W, Saleh N, Gao C, Gagea M, Vitija X, Kanada M Sci Rep. 2024; 14(1):27432.

PMID: 39521850 PMC: 11550812. DOI: 10.1038/s41598-024-79042-6.


The Role of Extracellular Vesicles in the Skin and Their Interactions with Nanoparticles.

Agobe F, DeLouise L World J Nanosci Nanotechnol. 2024; 1(1):17-21.

PMID: 39045530 PMC: 11265537.


Extracellular vesicle-mediated drug delivery in breast cancer theranostics.

Abdul-Rahman T, Roy P, Herrera-Calderon R, Khidri F, Omotesho Q, Rumide T Discov Oncol. 2024; 15(1):181.

PMID: 38780753 PMC: 11116322. DOI: 10.1007/s12672-024-01007-y.


Extracellular vesicles: a rising star for therapeutics and drug delivery.

Du S, Guan Y, Xie A, Yan Z, Gao S, Li W J Nanobiotechnology. 2023; 21(1):231.

PMID: 37475025 PMC: 10360328. DOI: 10.1186/s12951-023-01973-5.


Functional Biomaterials for Local Control of Orthodontic Tooth Movement.

Lin Y, Fu M, Harb I, Ma L, Tran S J Funct Biomater. 2023; 14(6).

PMID: 37367258 PMC: 10299595. DOI: 10.3390/jfb14060294.


References
1.
van der Pol E, Coumans F, Grootemaat A, Gardiner C, Sargent I, Harrison P . Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing. J Thromb Haemost. 2014; 12(7):1182-92. DOI: 10.1111/jth.12602. View

2.
Lammertink B, Deckers R, Storm G, Moonen C, Bos C . Duration of ultrasound-mediated enhanced plasma membrane permeability. Int J Pharm. 2014; 482(1-2):92-8. DOI: 10.1016/j.ijpharm.2014.12.013. View

3.
van der Pol E, Coumans F, Varga Z, Krumrey M, Nieuwland R . Innovation in detection of microparticles and exosomes. J Thromb Haemost. 2013; 11 Suppl 1:36-45. DOI: 10.1111/jth.12254. View

4.
Lazaro-Ibanez E, Neuvonen M, Takatalo M, Arasu U, Capasso C, Cerullo V . Metastatic state of parent cells influences the uptake and functionality of prostate cancer cell-derived extracellular vesicles. J Extracell Vesicles. 2017; 6(1):1354645. PMC: 5556667. DOI: 10.1080/20013078.2017.1354645. View

5.
Ortega F, Roefs M, Perez D, Kooijmans S, de Jong O, Sluijter J . Interfering with endolysosomal trafficking enhances release of bioactive exosomes. Nanomedicine. 2019; 20:102014. DOI: 10.1016/j.nano.2019.102014. View